Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Baliopharm

Baliopharm
2011 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
1 INVESTMENTS
Description

Developer of biotechnological therapeutic drugs in Basel, Switzerland. The company's products include therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn's disease, psoriasis and multiple sclerosis, enabling physicians and doctors to enhance their treatment procedures.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • St√§nzlergasse 4
  • 4051 Basel
  • Switzerland

+41 061 000 00 00

Baliopharm Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Baliopharm‘s full profile, request access.

Request full access to PitchBook

Baliopharm Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Santhera Pharmaceuticals Formerly VC-backed Pratteln, Switzerland 000 00000 0000 00000
0000000 Accelerator/Incubator Backed Wilmington, DE 00.00 0000000000
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
00000000 Formerly VC-backed South San Francisco, CA 00 00000 0000000000.
0000000 0000000000 Venture Capital-Backed Diepenbeek, Belgium 0 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Baliopharm Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 000000000000000 05-Jul-2016 0000 00000 00000 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Baliopharm Executive Team (1)

Name Title Board
Seat
Contact
Info
Andreas Herrmann Ph.D Chief Executive Officer